Pain and inflammation is a common complaint in most patients suffering from diseases. Non-steroidal anti-inflammatory drugs (NSAIDs) make up one of the largest groups of drugs used for pain and inflammation but causes side effects during their clinical uses. Therefore, the development of newer more potent anti-inflammatory drugs with lesser side effects is necessary.
INTRODUCTION
Inflammation is a normal protective response to tissue injury caused by physical trauma, noxious chemical or microbial agents. It is the body response to inactivate or destroy the invading organisms, to remove irritant and set the stage for tissue repair. It is triggered by the release of chemical mediators from injured tissue and migrating cells [1] .
Pain and inflammation is a common complaint in most patients suffering from disease conditions. Inflammation is a host defense mechanism to combat or overcome the invading pathogen or the foreign particles. Steroidal and Non-steroidal anti-inflammatory drugs (NSAIDs) are two main largest groups of drugs used for pain and inflammation [2] . Prolonged uses of both steroidal and non steroidal anti-inflammatory drugs are well known to be associated with many adverse effects [3] . Hence, search for new anti-inflammatory agents that retain therapeutic efficacy and causes less adverse effects is justified.
There is a growing interest in traditionally used medicinal plants which produce a variety of compounds having therapeutic properties [4] . One such medicinal plant used since ancient time is Aegle marmelos (L.) belongs to the family Rutaceae. Medicinal properties of Aegle marmelos were well explained in Ayurveda, Indian traditional medicine [5] .
Various chemical constituents like alkaloids, coumarins and steroids have been isolated and identified from different parts of tree such as leaves, fruits, wood, root and bark. Alcoholic extracts of the roots and fruits showed hypoglycemic and antidiabetic activity [6] . With respect to clinical applications, it should be noted that the roots are astringent, bitter and febrifuge. They are useful in diarrhea, dysentery, dyspepsia, stomachalgia, cardiopalmus, seminal weakness, and vomiting, intermittent fever, swellings.
Considering the traditional uses and demonstrated potential medicinal properties of Aegle marmelos, present study was undertaken to investigate its anti-inflammatory potential in chronic inflammation in rats.
METHODS AND MATERIAL
The plant material i.e. roots of Aegle marmelos were collected from Botanical garden, Mirpur, Dhaka. The plant was authenticated by National Herbarium (access no.36528), Mirpur, Dhaka. The root of Aegle marmelos was cut into pieces, shade-dried and grounded to coarse powder. Aqueous extract was prepared in distilled water in the ratio of 1:16, soaked overnight and boiled next day until the volume reduced to 1/4 th , cooled and drained [7] . 24 Long Evan Norwegian rats of either sex, weighing between 150-200g were kept under standard conditions of light and temperature, fed with animal pellets and allowed to drink water ad libitum.
Animals were divided into four groups each consisting of six rats. Chronic inflammation (granuloma) was induced by implanting one autoclaved cotton pellet (50 mg) subcutaneously to one groin of each rat on 1st day. They were treated as follows for 14 days: Group I served as control that received normal saline, Group II and Group III were given aqueous extract of A. marmelos root at a dose of 50 mg/kg and 100 mg/kg body weight respectively. Group IV were given indomethacin at a dose of 10 mg/kg body weight orally. Later on the 15 th day animals were anesthetized, the cotton pellets were removed, cleaned of the extraneous tissue and dried in a hot air oven to a constant weight and the dry weight of pellets were determined. The dry weight of the granuloma was difference between the final and initial weights of the cotton pellets. The percentage change of granuloma weight relative to control group was taken as an index of chronic anti-inflammatory activity.
It was calculated byPercent inhibition = 100 x (1-Wt / Wc).
Where, Wt = difference in pellet weight in drug treated group Wc = difference in pellet weight in drug untreated control group
RESULTS AND DISCUSSION
The chronic inflammation was induced by implanting one autoclaved cotton pellet weighting 50 mg subcutaneously at the groin region of each rat. The day of implantation was counted as day 1 and on the 15 th day animals were anesthetized and cotton pellet with granulation tissue were dissected out, cleaned of the extraneous tissue and dried in a hot air oven to a constant weight and the dry weight of pellets were determined. The weights were 110.40 ± 1.0 mg, 105.58 ± 0.36 mg, 102.14 ± 0.36 mg, 88.60 ± 0.30 mg, for group I, II, III and IV respectively.
Effects of Aqueous Extract of Aegle marmelos Root on Chronic Inflammation in Rats
In the study the mean initial weight of cotton pellets were 50.17 ± 0.02 mg. The increment in the weight of cotton pellet in aqueous extract of Aegle marmelos root 50mg/kg, aqueous extract of Aegle marmelos root 100 mg/kg and indomethacin 10mg/kg treated groups were 55.40 ± 0.36 mg, 51.96 ± 0.56 mg and 38.43 ± 0.28 mg respectively. Whereas, the increment of cotton pellet weight in control group was 60.22 ± 1.02 mg. The percentage of inhibition of granuloma formation were 8%, 13.72%, and 36.19% as compared to the control in aqueous extract of Aegle marmelos root 50 mg/kg, 100 mg/kg and indomethacin 10mg/kg treated groups respectively.
The percent inhibition with aqueous extract of A. marmelos root (8% and 13.72%) was comparatively less than that of indomethacin (36.19%). 
Increament of wt of cotton pellet
Cotton wool granuloma is a method for testing the proliferative phase i.e granuloma formation, provoked by the subcutaneous implantation of cotton pellets. The amount of newly formed connective tissue can be measured after removal and weighing the dried pellets. Though the A. marmelos showed less chronic anti-inflammatory activity compared to indomethacin, further assessment of A. marmelos with change in the dosage solvent extracts and other chronic inflammatory models, will throw a more light on its chronic anti-inflammatory activity.
Earlier studies showed a trend of anti-inflammatory activity of aqueous extract of Aegle marmelos root in chronic model studied [8] .
In previous study, three active compounds isolated from Aegle marmelos Correa, namely aegeline, skimmianine, and marmin. These compounds potently inhibited the histamine release from rat mast cells [9] .
In anoher study, Marmin isolated from Aegle marmelos Correa could inhibit the contraction of guinea-pig tracheal smooth muscle, in particular by interfering histamine receptors, inhibiting the histamine release from mast cells [10] .
CONCLUSIONS
The present study provides an initial step in demonstrating the anti-inflammatory effect of aqueous extract of Aegle marmelos root. The obtained data support the basis for future use of Aegle marmelos root in traditional system of medicine. Thus, it could be a new agent in reducing morbidity and mortality resulting from inflammatory disease conditions.
